Lifetime risks of common cancers among retinoblastoma survivors.
about
Radiation and breast cancer: a review of current evidenceDifferential role of RB in response to UV and IR damage.RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database.Risk definition and management strategies in retinoblastoma: current perspectivesUnderstanding pRb: toward the necessary development of targeted treatments for retinoblastomaTargeting Hsp90 in urothelial carcinomaMelanoma: from mutations to medicineSolid tumor second primary neoplasms: who is at risk, what can we do?Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerHigh risk of tobacco-related cancers in CDKN2A mutation-positive melanoma familiesDifferential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell modelConstitutional and occupational risk factors associated with bladder cancerIdentification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS).Cancer screening practices of adult survivors of retinoblastoma at risk of second cancersBreast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.Melanoma epidemiology, biology and prognosis.Genes and environment: effects on the development of second malignancies in retinoblastoma survivors.Differential gene expression profile of retinoblastoma compared to normal retinaVascular Recruitment of Human Retinoblastoma Cells by Multi-Cellular Adhesive Interactions with Circulating Leukocytes.Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapyUse of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model.Sarcomas in hereditary retinoblastomaFocal laser treatment in addition to chemotherapy for retinoblastoma.Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma.Genetic architecture of cancer and other complex diseases: lessons learned and future directions.At-risk populations for osteosarcoma: the syndromes and beyond.Variation of second cancer risk by family history of retinoblastoma among long-term survivors.Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patientsIrradiation-induced bone sarcoma in a patient treated for cervix cancer 28 years earlier.Familial and genetic risk of transitional cell carcinoma of the urinary tract.Retinoblastoma: concerning its initiation and treatment.Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951-2004.Global issues and opportunities for optimized retinoblastoma care.Retinoblastoma major review with updates on Middle East management protocols.Genetic profiling differentiates second primary tumors from metastases in adult metachronous soft tissue sarcoma.Cause-specific mortality in long-term survivors of retinoblastoma.Insights from mouse models into human retinoblastomaMalignant melanoma in the 21st century: the emerging molecular landscape.Hereditary bladder cancer.
P2860
Q24797050-CE8E85C1-AB5C-490C-9B7E-E5228CF2A371Q24802969-68E269A6-FF4B-4D38-A8B3-42F893DC09FDQ24813953-6AF6A1DB-BECF-469A-9606-FD8F88363E6DQ26849675-6A30FBAB-AFDD-448B-A484-EDCA77CB4392Q27011911-009FBC2E-6A2F-4DA8-AB8D-E1F678200BA9Q27023406-46006476-4093-43AE-BEA5-6273544BB653Q27024061-B83BFC51-6AC3-4C13-B3C0-1FE71A55C3B5Q27026266-AE5ED294-1B79-40D6-8DA8-EE5E4A8737FBQ28076041-1D743E22-ECB3-4059-B9D3-3246C27A4BAAQ28242124-648D9F97-41EB-4AEB-98D9-9FF02D052C95Q28472388-0CBA9D9C-55EF-4AF7-8384-90ABAC1A4725Q28585505-DD0A8473-472B-42D2-B839-E0004D802676Q30847332-FB828997-801D-42D2-ABE5-AB15EE200295Q33575528-FE291EC2-521F-45E1-8E73-CD7114693C92Q33613662-F2D0A5B1-3F4E-4974-8FA6-A60EF57D7AE0Q33698718-81799F70-76D6-4267-B1DF-93120DC36C3AQ33705736-FF2BE127-4EA2-4678-B664-8EB21E837A4DQ33994376-6A1F7B16-0677-475C-9C6F-1A5F65824E15Q34015100-24A24E91-5461-4222-856C-87C8D3C5AA2FQ34260518-8E3CC54B-A670-4DEB-8453-4295BA4BD766Q34346562-79224357-4BF0-434C-A220-967DE370519EQ34433701-9467F6A4-4447-4E90-A0D6-F83E24C05A4EQ34557627-13E6A27F-6D2B-40E3-92D6-316FC2278D8FQ34603733-36D493B6-5BAE-47CC-B343-C78783D92B51Q34633273-F62B8294-A1A4-40BD-ADA2-DA875B3659D4Q35117258-14A1705D-F4E3-4E5E-86DF-0F4C414E48DAQ35897747-016C6198-53B2-4EFA-83C7-2BFEE53D0BA9Q35925143-896102E7-6165-4788-9C73-A9001E880390Q36612348-110C5FE0-5204-4164-9B41-26F02A69BDC4Q36942455-47F19106-8203-49C1-928C-454A1D2680D0Q36951321-B90DAC7D-3A27-439B-A56D-2CA4F0CA7E0BQ36955766-3026AC06-790D-4EA6-A6CA-99B227BD143AQ36959083-6FDEDBE5-2D56-4C40-BE9A-CFC1C119C7A6Q36974502-95EEFED3-2ECA-4DCA-8347-8403B141C60FQ37060594-2D5A99A5-3553-4D69-A186-60E84B80950FQ37081447-CDC64434-3717-41BA-9B87-AFCE3FF32E0DQ37158597-8BD80C03-5E32-4B15-81F4-A949335CA15CQ37167727-E5ADC16A-D621-4931-A97D-BF71A97FF706Q37211362-40950802-1AB6-4958-B6A7-A8FF58CC95E1Q37278986-3D9FA456-0E45-42D5-9CF3-ED9872C56F8F
P2860
Lifetime risks of common cancers among retinoblastoma survivors.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Lifetime risks of common cancers among retinoblastoma survivors.
@ast
Lifetime risks of common cancers among retinoblastoma survivors.
@en
Lifetime risks of common cancers among retinoblastoma survivors.
@nl
type
label
Lifetime risks of common cancers among retinoblastoma survivors.
@ast
Lifetime risks of common cancers among retinoblastoma survivors.
@en
Lifetime risks of common cancers among retinoblastoma survivors.
@nl
prefLabel
Lifetime risks of common cancers among retinoblastoma survivors.
@ast
Lifetime risks of common cancers among retinoblastoma survivors.
@en
Lifetime risks of common cancers among retinoblastoma survivors.
@nl
P2093
P2860
P50
P356
P1476
Lifetime risks of common cancers among retinoblastoma survivors.
@en
P2093
Clare Gilham
Kristin Anderson
Marcelle Jay
P2860
P304
P356
10.1093/JNCI/DJH058
P407
P577
2004-03-01T00:00:00Z